BPC-157 is a research compound. It is not approved by the FDA or any regulatory body for human use. This article is for educational and informational purposes only. Nothing here constitutes medical advice. Consult a qualified physician before considering any peptide use.
BPC-157 is administered via subcutaneous or intramuscular injection, oral at 200-500 mcg once or twice daily. Subcutaneous injections into the abdominal fat or thigh are most common. Proper reconstitution with bacteriostatic water is required first.
How Do You Inject BPC-157?
BPC-157 is administered via subcutaneous or intramuscular injection, oral. For most researchers, subcutaneous injection is the standard approach — it's simple, relatively painless, and effective for Pentadecapeptide (15 amino acids) compounds.
This guide covers injection technique, site selection, needle choices, and common mistakes.
How Do You Prepare for a BPC-157 Injection?
Step 1: Wash your hands thoroughly.
Step 2: Clean the top of the BPC-157 vial and BAC water vial with alcohol swabs. If not yet reconstituted, see our BPC-157 reconstitution guide.
Step 3: Draw your dose (200-500 mcg) into an insulin syringe. Use our calculator for exact units.
Step 4: Clean the injection site with an alcohol swab and let it dry.
What Is the Correct Injection Technique?
Subcutaneous (most common): Pinch a fold of skin — typically abdominal fat 2+ inches from the navel, or the thigh. Insert the needle at a 45-degree angle. Push the plunger slowly and steadily. Hold for 5 seconds, then withdraw.
Intramuscular (less common for BPC-157): Insert the needle at 90 degrees into the muscle (deltoid or vastus lateralis). This route provides faster absorption but isn't necessary for most peptide protocols.
Rotate injection sites to prevent lipodystrophy (fat tissue changes from repeated injections in the same spot).
What Size Needle Should You Use?
For subcutaneous BPC-157 injections, 29-31 gauge insulin needles (½ inch or 8mm) are standard. These are thin enough to be nearly painless while long enough for proper subcutaneous delivery.
Use a fresh needle for every injection. Never reuse or share needles.
Calculate Your BPC-157 Dose
Use our free peptide dosing calculator to get exact reconstitution math and syringe units for BPC-157.
Open Calculator →What Are Common Injection Side Effects?
Mild redness, swelling, or itching at the injection site is normal and typically resolves within hours. Small bruises can occur, especially if you hit a capillary.
If you experience persistent pain, swelling, warmth, or redness lasting more than 24 hours, discontinue and consult a healthcare provider — these may indicate infection.
Bottom Line on BPC-157 Injection
BPC-157 is administered via subcutaneous or intramuscular injection, oral at 200-500 mcg once or twice daily. Subcutaneous injection with a 29-31 gauge insulin needle into abdominal fat is the standard technique. Rotate sites and use a fresh needle every time.
Complete Guide
BPC-157 : Research, Protocols & What the Studies Actually Say
Related Reading
- BPC-157 Dosage Guide
- BPC-157 Benefits
- BPC-157 Side Effects
- BPC-157 Stacking Guide
- BPC-157 Cycle Guide
- BPC-157 Research
Research-Grade Sourcing
If you're going to research BPC-157, source matters. These are the suppliers WolveStack has vetted for purity and third-party testing.
Frequently Asked Questions
What is BPC-157?
BPC-157 (Body Protection Compound-157) is a Pentadecapeptide (15 amino acids). Derived from a protective protein found in human gastric juice. It is researched for tissue repair, gut healing, tendon and ligament recovery, wound healing, neuroprotection.
What is the recommended BPC-157 dosage?
Common dosages: 200-500 mcg administered once or twice daily via subcutaneous or intramuscular injection, oral. Cycle length: 4-12 weeks. Half-life: approximately 4 hours (stable form). Use our peptide calculator for exact reconstitution math.
What are the side effects of BPC-157?
Generally well-tolerated in research. Minor injection site reactions reported. No significant adverse effects documented in animal studies at therapeutic doses. Long-term human safety data is not yet available.
Is BPC-157 safe?
BPC-157 has shown a favorable safety profile in research. Not FDA-approved. Available as a research chemical. Not scheduled or controlled. All research should follow appropriate safety protocols.